Evaluation of activated eosinophil infiltration for the assessment of the effect of chemosurgical treatment for allergic rhinitis using trichloroacetic acid

American Journal of Rhinology

Volumn 11, Issue 2, 1997, Pages 103-107

  Yao, Kazuo ^a,b   Shitara, Tetsuya ^a   Takahashi, Hio Omi ^a   Nishiyama, Kouichiro ^a   Iguci, Yoshiaki ^a   Yamamoto, Kazuhiro ^a   Okamoto, Makito ^a  

^a KITASATO UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; TRICHLOROACETIC ACID;

ADULT; ALLERGIC RHINITIS; ARTICLE; CHEMOTAXIS; EOSINOPHIL; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; SYMPTOM;

EID: 0030925713     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/105065897782537188     Document Type: Article

References (16)

1. Gleich GJ. Current understanding of eosinophil function. Hospital Practice 23:137-160, 1988.
2. Limaye AP, Abrahams JS, Silver JE, et al. Regulation of parasiteinduced eosinophilia: Selective increased interleukin 5 production in Helminth-infected patients. J Exp Med 172:399-402, 1990.
3. Coffman RL. T-helper heterogeneity and immune response patterns. Hospital Practice 24:101-133, 1989.
4. Springer TA. Adhesion receptors of the immune system. Nature 346:425-134, 1990.
5. Coffman RL, Seymour BWP, Lebman DA, et al. The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol Rev 102:5-28, 1988.
6. Plaut M, Pierce JH, Watson CJ, et al. Mast cell lines produce lymphokines in response to cross-linkage of Fc RI or to calcium ionophores. Nature 339:64-67, 1989.
7. Steffen M, Abboud M, Potter GK, et al. Presence of tumour necrosis factor or a related factor in human basophil/mast cells. Immunology 66:445-150, 1989.
8. Owen WF. Cytokine regulation of eosinophil inflammatory disease. Allergy Clinic Immunol News 3:85-89, 1991.
9. Kay AB. Asthma and inflammation. J Allergy Immunol 87:893-910, 1991.
10. Yao K, Shitara T, Takahashi H, Yagi A. Chemosurgery to inferior turbinates. Trichloroacetic acid application. J Otolaryngol Jpn 91:1031-1041, 1988.
11. Yao K, Shitara T, Takahashi H, Nishiyama K, Iguchi Y, Yamamoto K. Chemosurgery with trichloroacetic acid for allergic rhinitis. Am J Rhinology 9:163-168, 1995.
12. Yao K, Shitara T, Takahashi H, Nishiyama K, Iguchi Y, Yamamoto K. Evaluation of mucociliary function in patients with allergic rhinitis treated with trichloroacetic acid: Mucociliary transit time (Saccharin time) measurements. Am J Rhinology 9:in press, 1995.
13. Tai P-C, Spry CJF, Peterson C, et al. Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature 309:182-184, 1984.
14. Tai P-C, Capron M, Bakes DM, et al. Monoclonal antibodies to human eosinophil plasma membrane antigens enhance the secretion of eosinophil cationic protein. Clin Exp Immunol 63:728-737, 1986.
15. Tai P-C, Ackerman SJ, Spry CJF, et al. Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet 8534:643-647, 1987.
16. Sur S, Adolphson CR, Gleich GJ. Eosinophils. Biochemical and cellular aspects. Ch. 9. In: Allergy: Principles and Practices. 4th Ed. Middleton Jr E, Reed CE, Ellis EF, et al. (Eds), Mosby Publ., 1993, pp. 169-200.